国际预后积分系统
医学
内科学
一致性
危险分层
骨髓增生异常综合症
肿瘤科
置信区间
预测模型
总体生存率
骨髓
作者
Chantana Polprasert,Pimjai Niparuck,Thanawat Rattanathammethee,Sirorat Kobbuaklee,Theerin Lanamtieng,Ponlapat Rojnuckarin
出处
期刊:Hematology
[Maney Publishing]
日期:2022-12-15
卷期号:27 (1): 1301-1304
被引量:3
标识
DOI:10.1080/16078454.2022.2156682
摘要
Introduction Risk stratification is essential for treatment decision in myelodysplastic neoplasms (MDS). Molecular international prognostic scoring system (M-IPSS) has been recently developed combining somatic mutations and clinical information being used in the revised international prognostic scoring system (R-IPSS).Objective We aimed to explore the performances of M-IPSS and R-IPSS in Thai patients with MDS.Method MDS patients were stratified into risk categories using R-IPSS and M-IPSS scores. The performance of both models were evaluated for prognostic prediction.Results One hundred and sixty-two MDS patients were recruited from the multicenter study. Survival analysis revealed that both R-IPSS and M-IPSS were good prediction models with the Concordance Index (C-index) of 0.71 (95% Confidence interval [CI] 0.64–0.78) and 0.75 (95% CI 0.69–0.80), respectively (p = 0.22). Comparing the two, 13 of 162 (8%) cases were re-staged between lower and higher risks which would have affected treatment decisions.Conclusion Our study showed that R-IPSS score can be used for risk stratification in most Thai patients. A prediction model using somatic mutations specifically in Asian patients should be formulated in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI